IN SWEDISHStockholm3 has won the EIT Innovators Award 2017 which is given to products with exceptional value for individuals and society in Europe. The jury means that the benefit of Stockholm3 for Europe is very big and that the test should reach more Europeans as quickly as possible. At a pan-European level, Stockholm3 could reduce unnecessary and dangerous treatment for prostate cancer in 500,000 men while serious cancer is detected earlier.
The award was presented at a ceremony in Budapest on October 16, 2017.
Link to the EIT’s press release here.
The Stockholm3 test is a blood test that finds 20 percent more men with aggressive prostate cancer and at the same time reduces the number of unnecessary tissue samples by half compared to current practice. The Stockholm3 test has been tested on almost 60,000 men aged 50-70 and is based on research conducted at Karolinska Institutet.
